Catechol-O-methyltransferase activity in individuals with substance use disorders: a case control study

Area of Science:

• Neuroscience
• Psychiatry
• Pharmacology

Background:

• Substance use disorders (SUD) and impulsivity are linked to altered dopaminergic system functioning.
• Dopaminergic processes are crucial in regulating mood, motivation, and reward pathways.
• Investigating dopaminergic markers in offenders with SUD can elucidate underlying neurobiological mechanisms.

Purpose of the Study:

• To evaluate dopaminergic function in imprisoned individuals with SUD.
• To determine the relationship between soluble catechol-O-methyltransferase (s-COMT) activity and SUD-related behaviors.
• To explore potential neurobiological targets for addiction treatment.

Main Methods:

• Study included 46 male inmates from a Portuguese penal institution.
• Participants completed the Psychopathy Checklist-Revised (PCL-R), Barratt Impulsivity Scale (BIS-11), and European Addiction Severity Index (EuropASI).
• Erythrocyte s-COMT activity was measured and correlated with clinical assessments.

Main Results:

• 73.9% of participants had Antisocial Personality Disorder (ASPD); 58.7% had SUD.
• For the first time, s-COMT activity was significantly correlated with drug dependence severity (EuropASI).
• s-COMT activity also correlated with impulsivity factors: low self-control and non-planning (BIS-11).

Conclusions:

• This research provides novel insights into the dopaminergic function in individuals with SUD and impulsivity.
• Findings suggest s-COMT activity as a potential biomarker for SUD severity and impulsivity.
• Interfering with dopamine pathways via s-COMT modulation may offer new avenues for pharmacological addiction treatment.